Start with five lives
Small employers no longer have to make a funding decision from premium alone.
Traditional small-group and ICHRA quotes show price. Choice Benefits reveals the population, medical, prescription and projected-risk signals behind the next funding decision—even for employers starting at five eligible employees.
Risk intelligence has traditionally lived with large, data-rich employers. Choice Benefits makes a decision-ready version practical for small groups under 300—and creates a risk-informed strategy layer that has not historically existed in ICHRA.
Small employers no longer have to make a funding decision from premium alone.
Bring population-level intelligence to employers least likely to have an analytics team.
All Group, CHOICE Only, or a compliant class-based combination.
Risk, market pricing, contributions and employee experience in one strategy.
A de-identified workforce review found an older demographic profile, lower measured morbidity, concentrated GLP-1 and specialty-drug exposure, and no members projected above 10× risk. The outcome was a defensible comparison of both risk pools before renewal—not a predetermined answer.
Move beyond a static score. Each signal connects to a funding, contribution or care-access decision.
Age, geography, households, participation and permitted classes.
Morbidity, high-cost exposure, conditions and specialty prescriptions.
Group renewal pressure versus individual-market availability and pricing.
All Group, CHOICE Only or the strongest compliant combination.
Model the $5,000 report investment against the employer’s projected healthcare spend.
Analyze the census locally, then request the authorized secure destination for sensitive files.
Population analysis, authorized Medical + Rx intelligence, market comparison and a decision-ready funding recommendation.
Begin secure order →Schedule an investor or strategy meetingBring risk, market economics and employee choice into the same conversation.